6,7-dehydroxyleanone in salvia farinacea root with platelet aggregation inhibition

A technology for dehydrorolitone and platelet aggregation, which is used in medical preparations containing active ingredients, blood diseases, organic chemistry, etc.

Inactive Publication Date: 2006-10-25
XINJIANG MEDICAL UNIV
View PDF0 Cites 3 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, when activated, platelet membrane receptor binding sites are exposed and bind to fibrinogen leading to aggregation

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • 6,7-dehydroxyleanone in salvia farinacea root with platelet aggregation inhibition
  • 6,7-dehydroxyleanone in salvia farinacea root with platelet aggregation inhibition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0007] Example 1 Preparation and separation process of 6,7-dehydroroglitazone: see Figure 1.

Embodiment 2

[0008] Embodiment 2 6, the NMR spectrum data of 7-dehydroroglitazone

[0009] Red needle-like crystal (ethanol), mp170-171℃, soluble in benzene, chloroform and other low-polarity organic solvents.

[0010]

[0011] 1 H-NMR (500Hz, CDCl 3 ):

[0012] δ6.81 (1H, dd, J=9.5, 3, 7-H)

[0013] δ6.47 (1H, dd, J=9.5, 3, 6-H)

[0014] δ3.17 (1H, hept, J=10.8, 15-H)

[0015] δ2.89 (each 1H, d, J=13.5, 1-H)

[0016] δ2.14 (1H, t, J=3.25, 5-H)

[0017] δ1.22 (3H, d, J=10.8, 16-H)

[0018] δ1.23 (3H, d, J=10.8, 17-H)

[0019] δ0.98(3H, s, 18-H)

[0020] δ1.02 (3H, s, 19-H)

[0021] δ1.04 (3H, s, 20-H)

Embodiment 3

[0022] Example 3 Inhibition of platelet aggregation by 6,7-dehydroroolitazone

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

This invention relates to distill restraining blood platelet agglomeration from Xinjiang sage preparation method and pharmacodynamics experiment. The result reveals that comparing to normal saline, 6, 7-dehydrogenation enumerates ketone 2mg / ml group blood platelet restrain ratio is 56.2 percent, and 1mg / ml group blood platelet restrain ratio is 49.7 percent. So 6, 7-dehydrogenation enumerate ketone or extract contains it has good application of restrain blood agglomeration function and in anti cardiovascular diseases.

Description

technical field [0001] The invention relates to a method for extracting effective ingredients for inhibiting platelet aggregation from the root of the plant Sage sageii and its medicinal application. Background technique [0002] The principle of platelet aggregation: the mutual adhesion between platelets and platelets, and the aggregation into clumps is platelet aggregation. It is generally believed that its simple model is: platelet membrane receptor-connexin (regulatory protein)-platelet membrane receptor. The platelet membrane receptor is a glycoprotein complex, the connecting protein is fibrinogen, and the regulatory protein is thrombospondin or fibronectin or von Willebrand factor. Under resting conditions, 90% of platelets exist in complex form. However, when activated, platelet membrane receptor binding sites are exposed and bind to fibrinogen leading to aggregation. [0003] Xinjiang sage (Salvia deserta Schang), also known as Xinjiang D...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): C07C49/613A23L33/105A61K31/122A61P7/02A61P9/00
Inventor 热娜·卡斯木哈木拉提·吾甫尔堵年生王怀安王新玲王晓梅杨建
Owner XINJIANG MEDICAL UNIV
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap